Bristol-Myers Squibb Co. vs. Johnson & Johnson
Bristol-Myers Squibb Co. (BMY) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| BMY | JNJ | |
|---|---|---|
| Market Cap | $127.71 billion | $657.68 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| BMY | JNJ | |
|---|---|---|
| Dividend Yield | 4.03% | 1.98% |
BMY leads on 1 of 1 dividend factors.
Risk & Sentiment
| BMY | JNJ | |
|---|---|---|
| Short Interest | 0.39% | 0.67% |
BMY leads on 1 of 1 risk & sentiment factors.
Dig deeper: BMY overview, BMY financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
